A USA-based firm invests in early-stage biotech and pharma companies, mostly investing in seed to Series A rounds while it can also provide later funding (follow-up investment). The firm also seeks to In-licensing and NewCo spinout for later-stage research projects. The firm also has 30,000+ square feet of chemistry/biology incubator space.
The firm mainly looks at biopharmaceutical industry. The firm prefers to work closely with scientific innovators to advance discoveries rapidly through key value-inflection points.
The firm is seeking Seed to pre-IPO research-based U.S. companies developing novel drugs and biologics, with an underlying technology platform.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Leave a Reply